Synlogic merges with Caldera Therapeutics in a reverse IPO deal.
Synlogic signed a merger agreement acquiring Caldera Therapeutics, with Caldera's board approving the deal to provide cash to Synlogic. The transaction is valued at $100 million.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day